glossari
abc
anemia
blood
loss
coagulopathi
anh
acut
normovolem
hemodilut
coronaviru
diseas
doac
direct
oral
anticoagul
eact
eacta
european
associ
cardiothorac
surgeryeuropean
associ
cardiothorac
anaesthesiolog
ecdc
european
centr
diseas
prevent
control
esa
erythropoiesisstimul
agent
esmo
european
societi
medic
oncolog
eu
european
union
fio
fraction
inspir
oxygen
gi
gastrointestin
influenza
viru
subtyp
icu
intens
care
unit
ifpbmsabm
intern
foundat
patient
blood
managementsocieti
advanc
blood
manag
nat
nucleic
acid
test
nata
network
advanc
patient
blood
manag
haemostasi
thrombosi
nsaid
nonsteroid
antiinflammatori
drug
pbm
patient
blood
manag
pcc
prothrombin
complex
concentr
ppi
protonpump
inhibitor
sever
acut
respiratori
syndrom
coronaviru
sop
standard
oper
procedur
taco
transfusionassoci
circulatori
overload
trali
transfusionrel
acut
lung
injuri
wbc
white
blood
cell
world
health
organ
world
health
organ
declar
coronaviru
diseas
diseas
caus
sever
acut
respiratori
syndrom
coronaviru
pandem
global
health
care
face
unpreced
challeng
widespread
rapid
humantohuman
transmiss
high
morbid
mortal
worldwid
across
world
medic
care
hamper
critic
shortag
hand
sanit
person
protect
equip
ventil
hospit
bed
also
impedi
blood
suppli
blood
donat
center
mani
area
around
globe
mostli
close
donor
practic
social
distanc
either
ill
undergo
selfquarantin
quickli
diminish
drastic
public
health
initi
focus
contain
flatten
curv
invalu
resourc
deplet
countri
point
reach
demand
resourc
includ
donor
blood
outstrip
suppli
question
safeti
blood
persist
although
appear
like
viru
transmit
allogen
blood
transfus
still
remain
fulli
determin
option
dwindl
must
enact
region
nation
shortag
plan
worldwid
vital
dissemin
knowledg
immedi
implement
patient
blood
manag
pbm
pbm
evidencebas
bundl
care
optim
medic
surgic
patient
outcom
clinic
manag
preserv
patient
blood
multin
divers
group
author
issu
call
action
underscor
essenti
role
patient
blood
manag
manag
pandem
urg
stakehold
provid
implement
practic
commonsens
principl
pbm
multiprofession
multimod
approach
g
iven
recent
emerg
novel
sever
acut
respiratori
syndrom
coronaviru
ensu
worldwid
widespread
humantohuman
transmiss
relat
coronaviru
diseas
world
health
organ
declar
pandem
statu
viru
virusrel
diseas
one
corollari
public
health
author
blood
servic
concern
decreas
blood
donat
ultim
result
blood
shortag
unquestion
lead
difficult
controversi
transfus
ration
decis
frontlin
health
care
provid
consid
blood
perish
commod
short
expir
time
past
pandem
blood
servic
challeng
maintain
inventori
current
pandem
hand
analys
past
natur
manmad
disast
demonstr
either
chang
reduct
demand
blood
use
blood
suppli
challeng
pandem
influenza
viru
subtyp
pandem
signific
impact
blood
suppli
due
donor
fear
exposur
viru
hospit
freestand
donor
facil
similarli
pandem
alreadi
led
significantli
reduc
blood
suppli
due
cancel
numer
communitybas
mobil
blood
drive
well
mark
reduct
donor
arriv
schedul
appoint
instanc
result
current
pandem
restrict
congreg
social
distanc
date
unit
state
nearli
american
red
cross
blood
drive
cancel
across
countri
hospitalbas
collect
cancel
due
institut
concern
regard
donor
spread
hospit
patient
vice
versa
cancel
result
fewer
blood
donat
week
blood
american
red
cross
collect
come
drive
held
nonperman
collect
locat
accord
chief
execut
offic
new
york
blood
center
main
blood
supplier
new
york
citi
around
incom
blood
suppli
interrupt
week
march
school
busi
religi
institut
close
due
coronaviru
outbreak
moreov
number
elig
donor
cours
pandem
inevit
decreas
due
increas
number
individu
infect
selfquarantin
exposur
infect
person
person
investig
addit
blood
collect
facil
put
addit
screen
criteria
place
declin
donor
histori
travel
infect
hot
spot
preced
day
time
larg
proport
popul
travel
school
spring
break
final
older
person
often
repres
reliabl
donor
pool
also
appar
among
vulner
pandem
default
respons
reduc
blood
suppli
limit
capac
health
care
facil
suspens
elect
surgic
procedur
regardless
lack
uniform
definit
elect
yet
blood
util
urgent
emerg
intervent
actual
repres
greater
demand
blood
suppli
like
remain
unchang
like
true
chronic
transfusiondepend
patient
includ
malign
hematolog
condit
eg
sickl
cell
thalassemia
myelodysplast
syndrom
chemotherapyinduc
anemia
case
cancel
elect
surgeri
may
permit
diseas
progress
result
complex
urgent
situat
pandem
progress
call
blood
center
donor
suffici
allevi
problem
context
pandem
pressur
blood
collect
facil
hospit
transfus
medicin
servic
staff
also
increas
staff
member
requir
selfisol
selfquarantin
becom
ill
addit
effort
continu
standard
blood
donor
recruit
divert
part
grow
initi
manufactur
convalesc
plasma
patient
recov
treatment
option
remain
investig
limit
basi
current
major
sourc
demand
blood
donat
rapidli
evolv
natur
pandem
might
quickli
chang
landscap
creat
substanti
new
demand
also
note
suppli
chain
often
affect
travel
restrict
factori
close
decreas
manufactur
output
may
turn
affect
abil
blood
servic
maintain
test
product
facil
time
increas
need
anoth
remot
signific
issu
possibl
viru
transmiss
via
donat
blood
stage
pandem
expect
consider
percentag
popul
unknowingli
infect
includ
young
blood
donor
popul
asymptomat
case
common
absenc
nucleic
acid
test
nat
blood
donor
screen
exclud
albeit
theoret
time
possibl
transmiss
via
blood
transfus
donat
blood
may
contamin
thu
face
signific
unknown
futur
studi
elucid
true
risk
transfusiontransmit
reason
medic
commun
must
adopt
solut
continu
andor
resum
care
patient
popul
thu
immedi
global
implement
patient
blood
manag
pbm
mandat
pbm
defin
evidencebas
bundl
care
optim
medic
surgic
patient
outcom
clinic
manag
preserv
patient
blood
wwwifpbm
org
altern
time
applic
evidencebas
medic
concept
design
maintain
hemoglobin
concentr
optim
hemostasi
minim
blood
loss
effort
improv
patient
outcom
wwwsabmorg
nation
blood
author
australia
evidencebas
pbm
guidelin
exhaust
systemat
review
literatur
attend
rigor
methodolog
develop
recommend
practic
point
expert
opinion
point
modul
contain
recommend
practic
point
expert
opinion
point
pbm
toolbox
tabl
summar
practic
concept
pbm
numer
larg
observ
studi
sever
random
control
trial
metaanalys
demonstr
significantli
improv
patient
outcom
pbm
substanti
reduc
blood
util
concept
pbm
proactiv
focus
patient
need
well
condit
usual
lead
transfus
name
blood
loss
coagulopathi
platelet
dysfunct
anemia
pbm
shift
focu
reactiv
transfus
patient
allogen
blood
compon
prevent
measur
optim
manag
patient
blood
pbm
concept
endors
world
health
assembl
resolut
recommend
standard
care
european
commiss
recent
action
framework
advanc
univers
access
safe
effect
qualityassur
blood
compon
effect
implement
pbm
list
goal
despit
strong
recommend
avail
evid
demonstr
pbm
model
option
rather
necess
practic
chang
still
lag
far
behind
furthermor
expert
consensu
demonstr
pbm
model
improv
clinic
outcom
increas
patient
safeti
reduc
cost
hospit
organ
pbm
program
far
chang
cultur
across
institut
dissemin
evidencebas
pbm
guidelinesrecommend
detect
discourag
nonevid
practic
translat
evidencebas
guidelinesrecommend
clinic
practic
preand
postop
cell
recoveri
cell
saver
anh
pharmaceut
oralintraven
iron
folic
acid
vitamin
b
erythropoiesisstimul
agent
antifibrinolyt
tranexam
acid
aminocapro
acid
assess
march
state
implement
patient
blood
manag
pbm
strongli
advis
furthermor
interim
guidanc
march
maintain
safe
adequ
blood
suppli
pandem
recommend
good
patient
blood
manag
safeguard
blood
stock
current
pandem
set
sever
limit
avail
health
care
resourc
grow
shortag
donor
blood
clearli
support
rapid
implement
pbm
optim
way
forward
beyond
benefici
effect
blood
util
pbmassoci
improv
clinic
outcom
specif
reduct
hospitalacquir
infect
reduc
length
stay
may
decreas
burden
overwhelm
health
care
system
therefor
health
care
leader
clinician
urg
call
immedi
champion
chang
improv
institut
infrastructur
process
ensur
follow
identifi
evalu
treat
iron
defici
anemia
medic
surgic
patient
appropri
pharmacolog
agent
total
billion
peopl
world
popul
affect
anemia
repres
preval
impair
global
case
iron
defici
caus
anemia
howev
preval
anemia
hospit
patient
significantli
higher
gener
popul
reach
specif
surgic
popul
anemia
associ
increas
blood
util
wors
patient
outcom
increas
morbid
mortal
surgic
medic
patient
age
prevent
earli
diagnosi
prompt
treatment
direct
etiolog
anemia
decreas
blood
util
improv
patient
outcom
iron
defici
without
anemia
common
associ
increas
mortal
cardiac
surgeri
may
treat
oral
intraven
iron
supplement
oral
therapi
often
poorli
toler
slower
onset
action
intraven
iron
insuffici
correct
iron
defici
presenc
ongo
bleed
intraven
iron
therapi
prefer
intoler
oral
therapi
sever
anemia
ie
hemoglobin
gdl
plan
surgic
procedur
obstetr
deliveri
within
week
mani
formul
allow
rapid
safe
complet
correct
iron
defici
women
adolesc
girl
present
obstetr
care
instal
necessari
medic
devic
equip
reengin
clinic
pathway
infrastructur
allow
appropri
preoperativepreintervent
patient
assess
optim
ensur
appropri
wait
zone
treatment
area
particularli
preoperativepreintervent
patient
optim
form
multidisciplinari
pbm
committe
abbrevi
abc
anemia
blood
loss
coagulopathi
anh
acut
normovolem
hemodilut
doac
direct
oral
anticoagul
anemia
relat
nutrit
defici
folat
vitamin
b
may
mani
case
correct
oral
therapi
folat
vitamin
b
typic
dose
mg
daili
erythropoiesisstimul
agent
esa
exogen
form
erythropoietin
includ
epoetin
alfa
longeract
darbepoetin
alfa
emerg
esa
may
use
stimul
erythropoiesi
esa
often
use
longterm
manag
anemia
patient
chronic
kidney
diseas
chemotherapyinduc
bone
marrow
suppress
increas
expans
shortterm
use
preoper
anemia
particularli
anemia
deem
secondari
anemia
inflamm
preoper
patient
critic
ill
esa
util
either
unit
weekli
intens
care
unit
icu
preoper
period
result
higher
hemoglobin
concentr
reduc
transfus
util
identifi
rapidli
address
coagul
hemostat
issu
periop
coagulopathi
promptli
recogn
correct
perpetu
cycl
bleed
blood
util
patient
morbid
sever
evidencebas
strategi
avail
appropri
manag
coagulopathi
pointofcar
viscoelast
test
includ
thromboelastographi
rotat
thromboelastometri
facilit
near
realtim
identif
coagul
abnorm
therebi
allow
rapid
target
correct
impair
pathway
rather
reli
unguid
administr
plasma
platelet
transfus
therapi
often
avoid
altogeth
util
clot
factor
prothrombin
complex
concentr
fibrinogen
concentr
addit
transfusionspar
effect
clot
factor
also
decreas
risk
transfusionrel
complic
transfusionrel
acut
lung
injuri
trali
transfusionassoci
circulatori
overload
taco
lead
caus
transfusionrel
morbid
mortal
antifibrinolyt
agent
includ
tranexam
acid
epsilon
aminocapro
acid
wide
avail
inexpens
highli
effect
safe
pharmacolog
agent
may
use
stabil
clot
format
prevent
hyperfibrinolysi
use
agent
consist
associ
bleed
reduct
transfus
reduct
improv
outcom
across
numer
surgic
procedur
trauma
set
use
effect
blood
conserv
method
medic
surgic
patient
numer
modal
avail
periop
blood
conserv
includ
avoid
hemodilut
restrict
transfus
strategi
type
allogen
blood
compon
optim
physiolog
respons
anemia
earli
treatment
coagulopathi
use
topic
hemostat
agent
cell
salvag
involv
collect
patient
blood
loss
filter
wash
ensur
remov
impur
direct
return
autolog
compon
patient
associ
reduct
allogen
blood
compon
util
therefor
recommend
procedur
moderatetolarg
volum
blood
loss
acut
normovolem
hemodilut
anh
process
control
volum
patient
blood
remov
surgic
insult
follow
replac
crystalloid
colloid
adult
result
less
red
blood
cell
loss
surgic
procedur
allow
reinfus
autolog
blood
rich
red
blood
cell
platelet
clot
factor
need
intraop
postop
anh
provid
autolog
fresh
whole
blood
sequest
deliv
red
blood
cell
plasma
platelet
need
use
like
benefici
procedur
signific
blood
loss
anh
thu
consid
casebycas
basi
medic
surgic
patient
also
essenti
limit
iatrogen
blood
loss
often
occur
diagnost
phlebotomi
method
reduc
iatrogen
blood
loss
includ
minim
unnecessari
blood
sampl
use
pediatr
small
vacuum
blood
draw
allow
test
hospit
autom
chemistri
line
employ
closedloop
sampl
devic
care
monitor
patient
condit
surgeri
rapidli
interven
either
intervent
radiolog
endoscopi
unexpect
bleed
depend
sourc
bleed
postop
postobstetr
deliveri
common
associ
increas
resourc
util
wors
clinic
outcom
therefor
essenti
patient
receiv
serial
evalu
bleed
includ
assess
drain
output
frequent
monitor
hemodynam
statu
physic
examin
patient
suspect
bleed
coagulopathi
pointofcar
viscoelast
test
hemoglobin
assess
may
use
rapid
identif
bleed
coagul
abnorm
well
rapid
employ
surgic
intervent
radiolog
intervent
immedi
achiev
sourc
control
thoroughli
inform
educ
medic
profession
patient
caregiv
import
pbm
involv
patient
treatment
manag
decis
obtain
formal
consent
import
involv
key
stakehold
decisionmak
process
let
know
wellb
health
love
one
center
comprehens
effort
patient
chronic
transfus
need
prompt
frequent
messag
reassur
effort
deploy
maintain
access
transfus
difficult
decis
need
made
patient
requir
massiv
transfus
traumat
injuri
gastrointestin
bleed
cardiovascular
surgeryal
poor
chanc
shortand
longterm
surviv
transfus
multipl
unit
blood
compon
singl
patient
associ
high
morbid
mortal
massiv
transfus
could
also
compromis
transfus
support
mani
patient
need
face
substanti
challeng
pandem
left
one
worldwid
safe
unaffect
medic
contributionslarg
smallar
urgent
need
provid
optim
compassion
care
use
everi
modal
conserv
resourc
appropri
resourc
conserv
allow
better
alloc
patient
absolut
need
author
call
action
document
repres
divers
background
specialti
yet
come
togeth
cohes
messag
underscor
essenti
role
patient
blood
manag
manag
pandem
urg
implement
practic
commonsens
principl
pbm
multi
